Zydus Lifesciences Limited
ZYDUSLIFE
株式のランク
#1750
Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952,... Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952, operates globally in the pharmaceutical and consumer goods sectors. Renamed from Cadila Healthcare Limited in February 2022, the company manages the entire lifecycle of pharmaceutical products, from research and development to manufacturing, marketing, and distribution. Its extensive reach covers India, the United States, Europe, Latin America, the Asia Pacific region, and Africa. The company's pharmaceutical division provides a broad spectrum of offerings, including finished dosage human formulations (such as generics, branded generics, and specialized treatments like biosimilars and vaccines), as well as active pharmaceutical ingredients (APIs). Zydus focuses on therapeutic areas like pain management, neurology, dermatology, and liver diseases, among others. Additionally, it is developing a pipeline of biological products aimed at conditions such as oncology, autoimmune disorders, nephrology, ophthalmology, inflammation, rheumatology, hepatology, and infectious diseases. In its consumer products segment, Zydus offers popular wellness brands including Complan, the EverYuth range of skincare products, Nycil, Glucon-D glucose powder, Nutralite, and the Nutralite Doodhshakti dairy product line. Beyond these core operations, the company is also involved in investment activities, animal health and veterinary services, pharmacy retail, and human resource supply and administration.
株価
$12.04
時価総額
$12.01B
変化（1日）
-2.15%
変化（1年）
6.00%
国
IN
取引 Zydus Lifesciences Limited (ZYDUSLIFE)
カテゴリー
Healthcare
Zydus Lifesciences Limited（ZYDUSLIFE）の発行済株式数
June 2026 時点の発行済株式数 1.01B
Zydus Lifesciences Limited の最新の財務報告および株価によると、現在の発行済株式数は 1.01B です。March 2025 の終わりには、同社は 1.01B 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Zydus Lifesciences Limited（ZYDUSLIFE）の発行済株式数の履歴（2004 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 1.01B | -0.12% |
| 2025 | 1.01B | -0.55% |
| 2024 | 1.01B | -0.37% |
| 2023 | 1.02B | -0.79% |
| 2022 | 1.02B | 0.00% |
| 2021 | 1.02B | 0.00% |
| 2020 | 1.02B | 0.00% |
| 2019 | 1.02B | 0.00% |
| 2018 | 1.02B | 0.00% |
| 2017 | 1.02B | 0.00% |
| 2016 | 1.02B | 0.00% |
| 2015 | 1.02B | 0.00% |
| 2014 | 1.02B | 0.00% |
| 2013 | 1.02B | 0.00% |
| 2012 | 1.02B | 0.00% |
| 2011 | 1.02B | 0.00% |
| 2010 | 1.02B | 0.00% |
| 2009 | 1.02B | 8.67% |
| 2008 | 942.10M | 0.00% |
| 2007 | 942.10M | 0.00% |
| 2006 | 942.10M | 100.00% |
| 2005 | 471.05M | 0.00% |
| 2004 | 471.05M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 138.71% |
IN
|
